Read more

October 30, 2019
2 min read
Save

IOP fluctuation may predict rate of visual field deterioration

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Fluctuating IOP was a significant and independent predictor for subsequent visual field deterioration in patients with primary angle closure glaucoma, according to findings published in the British Journal of Ophthalmology.

Perspective from Derek MacDonald, OD, FAAO

Carol Y. Cheung, PhD, and colleagues examined the relationship of IOP control with subsequent visual field deterioration in patients with primary angle closure disease (PACD).

“Robust evidence is lacking for defining the target IOP for PACD patients, and it’s still unclear whether lowering IOP to below the population mean helps in slowing the [visual field] deterioration in [primary angle closure glaucoma], which is structurally different from [primary open angle glaucoma] and may involve different disease processes,” Cheung, an assistant professor in the department of ophthalmology and visual sciences at the Chinese University of Hong Kong, and colleagues wrote.

The researchers studied 419 eyes of 240 Chinese patients with PACD. Mean IOP and IOP fluctuation were examined.

Cheung and colleagues found that greater IOP fluctuation was significantly associated with visual field deterioration, independent of mean IOP.

The researchers wrote that patients with high-threshold mean IOP and high-threshold IOP fluctuation had the most rapid visual field deterioration compared with eyes with low-threshold IOP fluctuation (P < .05).

In eyes with high-threshold mean IOP, patients with high-threshold IOP fluctuation had a faster rate of visual field deterioration compared with eyes with low-threshold IOP fluctuation (P = .01).

“We propose that for patients with PACD whose IOP is already within the normal range, it is worthwhile to consider minimizing IOP fluctuation by more close monitoring and careful titration of treatment according to each patient’s clinical course,” the authors said. – by Earl Holland Jr.


Disclosures: The authors report no relevant financial disclosures.